Monday, March 22, 2010

Nodality Nabs $15.5M

South San Francisco-based Nodality said today that it has raised $15.5M in a new funding round. The round was led by Pfizer Ventures, and also included Laboratory Corporation of America Holdings, Kleiner Perkins Caulfield & Byers, TPG Biotechnology, and Maverick Capital. Nodality said the funding will go towards commercial launch of its first test in acute myelogenous leukemia, as well as for its other research and development programs. Nodality is focused on developing personalized medicine tests in cancer and autoimmune disease. More information »